DCF — PRESENCE RESURRECTION MEDICAL CENTER
Enterprise Value: $-284.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-284.4M
Enterprise Value
$-95.2M
PV of Cash Flows
$-189.3M
PV of Terminal Value
$-304.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $331.9M | $-14.9M | -4.0% | $-28.9M | $-26.3M |
| Year 2 | $341.8M | $-11.9M | -3.0% | $-26.4M | $-21.8M |
| Year 3 | $352.1M | $-8.8M | -2.0% | $-23.7M | $-17.8M |
| Year 4 | $362.6M | $-7.2M | -2.0% | $-22.6M | $-15.4M |
| Year 5 | $373.5M | $-6.5M | -2.0% | $-22.3M | $-13.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-284.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$322.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04988731996315915
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5